Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$6.47 - $9.57 $171,636 - $253,872
-26,528 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $77,481 - $115,965
8,590 Added 47.89%
26,528 $245,000
Q3 2021

Nov 16, 2021

BUY
$13.71 - $17.18 $11,283 - $14,139
823 Added 4.81%
17,938 $255,000
Q2 2021

Aug 13, 2021

BUY
$14.92 - $23.23 $255,355 - $397,581
17,115 New
17,115 $284,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $518M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.